Epidemio-clinical profile of sickle cell disease and prediction of pharmacokinetic and toxicological properties of drugs used in its management at the Mixed Medicine and SS Anemia Center (Kinshasa, DR Congo)
Article Sidebar
Main Article Content
Abstract
Sickle cell disease or SS anaemia is the most common haemoglobinopathy in the world and is a major public health problem in endemic
regions. The aim of the present study was to conduct a survey in a specialised centre in order to evaluate the cost of care, to identify the
infectious diseases associated with sickle cell disease and the drugs used to combat them and then to predict the pharmacokinetic and
toxicological properties of these drugs and of the phyto-markers contained in Lippia multiflora, a plant used in the alternative management of
this haemoglobinopathy. This study shows that the female sex is more numerous than the male sex (54.5% vs. 45.5%); the 6-15 year age
group is predominant (81%); the major complications noted are sepsis (62%); broad-spectrum antibiotics are prescribed for 87.5% while
antimalarials are prescribed for 47.0%; the cost of care for sickle cell disease patients is estimated at more than 100 USD (˃200. 000 CDF) for
52.5% of patients for each crisis; the management of sickle cell disease by traditional medicine combined with modern medicine, particularly
the combination of plant extracts with antibiotics, represents a risk of drug interaction for patients. It is therefore desirable that further studies
be conducted on the antibacterial activity of Lippia multiflora to verify whether this plant is not endowed with intrinsic activity against the
bacteria associated with sickle cell disease.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
References
Alain, F., Rahariniainasoa, A.A., Rakotondratsara,
M.A., Betombo, F., Ramanarivo, N.M.,
Andrianarimanana, D., Rabesandratana, H.N.,
Rabenandrianina, T.T.H., & Rakoto, A. O.
(2022). Étude épidémio-clinique de la
drépanocytose chez l’enfant au service de
pédiatrie du Centre Hospitalier Universitaire
MAHAJANGA. Revue Malgache de Pédiatrie,
(2), 98-105.
Carter, R., Wolf, J., van Opijnen, T., Muller, M.,
Obert, C., Burnham, C., Mann, B., Li, Y.,
Hayden, R.T., Pestina, T., Persons, D., Camilli,
A., Flynn, P.M., Tuomanen, E.I., Rosch, J.W.
(2014). Genomic analyses of pneumococci from
children with sickle cell disease expose hostspecific bacterial adaptations and deficits in
current interventions. Cell Host Microbe 15(5),
-599. doi: 10.1016/j.chom.2014.04.005.
Diagne, I., Diagne-Gueye, N.D., Signate-Sy, H.,
Camara, B., Lopez-Sall, P., Diack-Mbaye, A.,
Sarr, M., Ba, M., Sow, H.D., & Kuakuvi, N.
(2003). Management of children with sickle cell
disease in Africa: experience in a cohort of
children at the Royal Albert Hospital in Dakar.
Médecine Tropicale, 63(4-5), 513-520.
Dosso, M., Bissagnene, E., Coulibaly, M., Kette, P.,
N'Douba, A., Guessennd, N., Diaha, H., Bouzid,
S.A., Akoua, K., & M'Bengue, A. (2000).
Gnagne Adou, K. Fofana, A. Kadio, Résistances
acquises et prescriptions d'antibiotiques en
Afrique: quelles adéquations? Médecine et
Maladies Infectieuses, 30(3), s197-s204.
https://doi.org/10.1016/S0399-077X(00)89090-
Girot, R., Begué, P., & Galacteros, F. (2003). La
drépanocytose. Paris, Editions John LIBBEY
Eurotext.
Kambale, J.K., Ngbolua, K.N., Mpiana, P.T.,
Mudogo V., Tshibangu, D.S.T., Wumba,
D.M.R., Mvumbi, L.G., Kalala, L.R., Mesia,
K.G., & Ekutsu, E. (2013).Evaluation in vitro de
l’activité antifalcémiante et effet antioxydant
des extraits d’Uapaca heudelotii Baill. Int. J.
Biol. Chem. Sci., 7(2), 523-534.
Kunle, O.F., & Egharevba, H.O. (2013). Chemical
constituents and biological activity of medicinal
plants used for the management of sickle cell
disease - A review, J Med Plants Res., 7(48),
-3476.
Labie, D. (2010). Les relations complexes entre
hémoglobinopathies et paludisme.
Médecine/Science (Paris) 26: 685–687.
https://doi.org/10.1051/medsci/2010268-9685.
Labie, D., & Elion, J. (2014). Chez les
drépanocytaires, le pneumocoque se joue de la
prévention et s’adapte à la maladie :
Conséquences vaccinales. Médecine/Science
(Paris) 30, 946–948.
https://doi.org/10.1051/medsci/20143011005.
Masengo, A.C., Bongo, G.N., Robijaona, B., Ilumbe,
G.B., Ngbolua, K .N., & Mpiana, P.T.
(2021a).Étude ethnobotanique quantitative et
valeur socioculturelle de Lippia Multiflora
Moldenke (Verbenaceae) à Kinshasa,
République Démocratique du Congo. Rev. Mar.
Sci. Agron. Vét., 9(1), 93-101.
Masengo, A.C., Djolu, D.R., Kumbali, N.G.,
Pangodi, A., Motuta, A.C., Baholy, R.R.,
Mpiana, P.T., Mudogo, V., & Ngbolua, K.N.
(2020). Profil épidémiologique et clinique du
Paludisme et de la drépanocytose à l’hôpital
général de référence de Gbado-lite (NordUbangi) en République Démocratique du
Congo. International Journal of Applied
Research, 6(2), 240-246.
Masengo, A.C., Ngbolua, K.N., Gbolo, Z.B., Inkoto,
L.C, Baholy, R., Iteku, B.J, Ilumbe, B.G., &
Mpiana, P.T. (2021b). Drépanocytose:
Approche Bioclinique, Cibles Biologiques
d’Intérêt Thérapeutique et Perspectives.
International Journal of Progressive Sciences
and Technologies, 28(2), 539-545.
Mashako, M.R., Bitwe, R.M., Nsibu, C.N., &
Mashako, Y.K. (2019). Profil épidémiologique
et clinique de la drépanocytose à l’hôpital
provincial du Nord-Kivu. Revue Malgache de
Pédiatrie, 2(2), 62-69.
Mitchell, T.J., & Mitchell, A.M. (2014).
Pneumococcus adapts to the sickle cell host.
Cell Host Microbe, 15, 521-523.
https://doi.org/10.1016/j.chom.2014.04.013.
Mpiana, P.T., Kimbadi, B.L., Ombeni, A.M.,
Ngbolua, K.N., Tshibangu, D.S.T., Tshilanda,
D.D., Wimba, L., , Mushagalusa, F., & Muyisa,
S. (2013). In vitro inhibitory effects and antisickle erythrocytes haemolysis of Dicliptera
colorata C.B. Clarke, Euphorbia hirta L. and
Sorghum bicolor (L.) Moench. Open Journal of
Blood Diseases, 3, 43-48. doi:
4236/ojbd.2013.31009.
Mpiana, P.T., Ngbolua, K.N., & Tshibangu, D.S.T.
(2016). Les alicaments et la drépanocytose : une
mini-revue. Comptes Rendus Chimie, 19 (7),
-889. DOI: 10.1016/j.crci.2016.02.019.Mpiana, P.T., Tshibangu, D.S.T., Shetonde, O.M. &
Ngbolua K.N. (2007). In vitro
antidrepanocytary activity (anti-sickle cell
anaemia) of some Congolese plants.
Phytomedicine, 14, 192-195.
Navarette, S., & Saussays C. (2011). Les interactions
entre plantes et médicaments. Sciences
pharmaceutiques. dumas-00641779.
Ngbolua, K.N. (2019). Evaluation de l’activité antidrépanocytaire et antipaludique de quelques
taxons végétaux de la République démocratique
du Congo et de Madagascar. Editions
Universitaires Européennes, Riga: Latvia. .
Ngbolua, K.N., & Djolu D.R. (2019). Étude
pharmaco-biologique de Sarcocephalus
latifolius (Rubiaceae): Plante antidrépanocytaire de Tradition en République
Démocratique du Congo. Editions
Universitaires Européennes, Riga: Latvia..
Ngbolua, K.N., Inkoto, C., & Masengo, A.C. (2019).
Criblage phytochimique et biologique de trois
taxons végétaux traditionnellement utilisés
contre la drépanocytose en République
Démocratique du Congo. Editions
Universitaires Européennes, Riga: Latvia.
Ngbolua, K.N., Mpiana, P.T., & Mudogo, V. (2019).
Pharmacopée Traditionnelle et Lutte contre la
Drépanocytose: Méthodes de sélection et
d’évaluation de l’activité des plantes
médicinales. Riga, Editions Universitaires
Européennes.
Wembonyama, S.O. (2021). Moringa oleifera, une
aubaine dans la prise en charge du syndrome
drépanocytaire majeur? Journal of Medicine,
Public Health and Policy Research, 1(1), 31-35.